BioPacific Investors


BioPacific Investors is...
An angel investment group created to leverage cross-pacific business opportunities 
by investing in early stage life science and healthcare companies with an Asia connection
  • Provide a funding source to emerging life science and healthcare companies that have a business focus on China/Asia and are pre-venture capital or do not fit traditional funding models
  • Identify and present well-vetted cross-border investment opportunities to the membership
  • Simplify the investment vehicle for members, companies and follow-on investors
  • Contribute business, scientific and regional expertise to companies to improve probability for success     
  • Founded and managed by angel investors and life science executives with broad cross-pacific experience
  • Non-profit member organization (501(c)6) with investments made through a for-profit LLC
  • Operations funded by sponsors including Dorsey & Whitney, ChinaBio and others, and membership dues
  • No override or management fees; all of investors’ funds go to the companies
  • All work performed by members on a pro bono basis except Managing Director
  • 60+ members in US, China, Japan, Korea, India, Singapore & Australia; offices in Palo Alto & Shanghai
  • Individual members must be accredited investors with business or scientific expertise in life sciences
  • Affiliate members include VC/PE firms and multinational corporations with a focus on life science
  • Members must be recommended by two existing members and be accepted by Membership Committee
  • Minimum investment requirement of $25,000/year; $2,000/year individual membership fee
Investment Opportunities
  • Broad life science focus: pharma/biotech, medtech, diagnostics, digital health & healthcare services
  • Robust deal flow of 350+ deals/yr from founders, members, sponsors, venture capitalists and universities
  • Screening Committee reviews all investment opportunities and selects those to present to membership
  • Five member investment meetings/year with ~two presenting companies (30 min. each)
  • No charge to submit business plans or present to membership (if selected)
  • Targeted investment range of $250,000 to $1 million per investment; potential to syndicate larger deals
  • Companies must have or plan to have a presence in China or elsewhere in Asia
Contact Information
For membership or sponsorship information:                              BioPacific Investors, Inc.
       Ann Gaddy, Managing Director                                           Palo Alto, San Diego, Shanghai                              

ChinaBio Group is a sponsor of BioPacific Investors, but has no legal or financial interest and does not benefit from investments made by any other party.



ChinaBio Events

ChinaBio® Partnering Forum 2022

Beijing and Digital
September 13-16, 2022

Other Events